C
Power Law company profile
Centessa Pharmaceuticals
Biotech & Life Sciences · Boston, United States · Founded 2021 · IPO 2021 Unicorn
Valuation
$5.93B
Market cap · Apr/2026
Revenue
$15M
Latest reported FY
Global footprint
Where Centessa Pharmaceuticals has talent and traffic
Web traffic by country
21K
monthly visits
across markets
across markets
🇺🇸 United States81%
🇬🇧 United Kingdom10%
🇮🇳 India4.8%
🇧🇪 Belgium2.4%
Patent intelligence
$34M patent portfolio · 12 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$34M
0.57% of market cap · comparable to top peer Advanced Accelerator Applications ($23M)
12 active patent families
Where Centessa Pharmaceuticals innovates
PeptideAntigen processingMolecular biologyT cellAntigen Processing Cell
Above peer median on Market
Quality vs same-sector peers
Centessa Pharmaceuticals on the five Patsnap quality dimensions
Centessa Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Centessa Pharmaceuticals concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Centessa Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Centessa Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.